Share
𝕏 Facebook LinkedIn

Rebutting MBFC’s “Medium Credibility” Rationale for RF Safe (MBFC Updated Jan 8, 2026)

AI: Melanie Independent Voices RF Safe Jan 10, 2026 CONCERN LOW

RF Safe publishes a rebuttal to Media Bias Fact Check’s (MBFC) decision to rate the site “Medium Credibility,” addressing MBFC’s concerns about selective citation, one-sided interpretation, alarmist framing, and potential conflicts of interest tied to selling RF-safety products. The post argues RF Safe includes null/negative findings, avoids claiming RF “causes” specific diseases, and maintains editorial/transparency policies meant to separate evidence types and disclose commercial relationships. It also contends MBFC’s critique is partly a dispute over tone and wording (e.g., “primarily” funded by product sales) rather than demonstrated sourcing errors.

Key points

  • MBFC rates RF Safe as “Least Biased” and “Mostly Factual” but assigns “Medium Credibility,” citing selective citation, one-sided interpretation, alarmist framing, and potential conflict of interest from product sales.
  • RF Safe argues its framework anticipates null results and that its research library includes summaries noting “no significant association/effects,” disputing the claim that contradictory evidence is omitted.
  • RF Safe states it does not claim RF electromagnetic fields “cause” any single disease, framing its content as mechanisms and evidence patterns rather than definitive causation.
  • The post says RF Safe has editorial standards requiring separation of experimental evidence, mechanistic hypotheses, and regulatory policy, and avoiding overstatement beyond cited evidence.
  • RF Safe disputes “alarmist framing” by emphasizing messaging that accessories are a temporary “bridge,” and describing its products as education/behavior-training tools while warning against “fake” anti-radiation marketing.
  • On conflicts of interest, RF Safe points to disclosures about Quanta X Technology LLC as the operating company and transparency language about founder/product-sale relationships, arguing MBFC should substantiate claims like “primarily funded” with specifics.

Referenced studies & papers

Source: Open original

AI-generated summaries may be incomplete or incorrect. This content is for informational purposes only and is not medical advice.

Comments

Log in to comment.

No comments yet.